This Week in the Circuits: Insurers Defend Decision to Not Cover Popular Weight-Loss Drugs

Oct. 4, 2025, 11:00 AM UTC

Welcome to This Week in the Circuits, a look at the most significant cases before federal appeals courts.

Cigna Health is facing allegations of violating Affordable Care Act discrimination protections when it refused to cover popular weight-loss drugs such as Novo Nordisk‘s Ozempic for a University of Maine System employee who claims she was prescribed the drug for obesity treatment.

On Monday, the US Court of Appeals for the First Circuit will hear Jamie Whittemore’s arguments that her obesity counts as a disability and that Cigna is illegally discriminating against her and others for excluding weight-loss drugs from ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.